← Back to Search

Group Language Therapy for Aphasia

N/A
Waitlist Available
Led By Dana Moser, Ph.D
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of adult-onset aphasia
Age 18 years or older
Must not have
No history of major psychiatric illness, cognitive impairment, or neurological disorders such as seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-week post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of group participation on adults with aphasia.

Who is the study for?
This trial is for adults over 18 who were proficient in English before having a stroke that led to aphasia, impacting their language abilities. They must have good enough vision and hearing for assessments but can't join if they had childhood speech issues, major psychiatric illnesses, cognitive impairments, or other neurological disorders.
What is being tested?
The study tests the effectiveness of group sessions focused on improving reading and writing skills in individuals with aphasia due to stroke. Participants will undergo language ability assessments before and after attending weekly 90-minute reading group sessions for an academic semester.
What are the potential side effects?
Since this intervention involves educational activities rather than medical treatments, traditional side effects are not applicable. However, participants may experience fatigue or frustration during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with aphasia as an adult.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have no major psychiatric, cognitive, or neurological issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-week post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-week post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reading Comprehension Battery for Aphasia-2 (RCBA-2; LaPointe & Horner, 1998) Scores
Secondary study objectives
Communication Confidence Rating Scale for Aphasia (CCRSA; Babbitt & Cherney, 2010)
Discourse Production Task
Gray Oral Reading Test (GORT; Wiederholt & Bryant, 2012)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Reading GroupExperimental Treatment1 Intervention
All participants in this group will receive language intervention within weekly group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
496 Previous Clinical Trials
150,624 Total Patients Enrolled
Dana Moser, Ph.DPrincipal InvestigatorUniversity of Arkansas

Media Library

Language intervention with group sessions and independent tasks Clinical Trial Eligibility Overview. Trial Name: NCT05520528 — N/A
Rehabilitation Research Study Groups: Reading Group
Rehabilitation Clinical Trial 2023: Language intervention with group sessions and independent tasks Highlights & Side Effects. Trial Name: NCT05520528 — N/A
Language intervention with group sessions and independent tasks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05520528 — N/A
~8 spots leftby Jul 2025